Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy

Francesca Cuomo1, Lucia Altucci2, Gilda Cobellis3

  • 1Department of Precision Medicine, University of Campania "L. Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy. francesca.cuomo@unicampania.it.

Cancers
|October 2, 2019
PubMed

Insights

Autophagy, a cellular process for degrading damaged components, is vital for cell survival and quality control. Its dysfunction links to diseases like cancer, prompting research into autophagy-targeting drugs.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Autophagy is a fundamental cellular process involving the degradation of damaged organelles and proteins.
  • It plays a crucial role in cellular quality control and energy homeostasis, acting as a pro-survival mechanism.
  • Dysregulation of autophagy is implicated in various pathologies, including neurodegeneration, metabolic disorders, and cancer.

Purpose of the Study:

  • To provide a comprehensive overview of the regulatory mechanisms governing autophagy.
  • To specifically examine the role of autophagy in cancer development and progression.
  • To review currently approved autophagy-targeting drugs for treating malignancies.

Main Methods:

  • Literature review of autophagy regulation.
  • Analysis of autophagy's role in oncogenesis.
  • Survey of approved autophagy-targeting therapeutics.

Main Results:

  • Autophagy's complex regulatory network influences cellular fate.
  • Aberrant autophagy is a hallmark of many cancers, impacting tumor growth and response to therapy.
  • Several drugs targeting autophagy are approved for treating solid and non-solid tumors.

Conclusions:

  • Understanding autophagy regulation is key to developing novel cancer therapies.
  • Targeting autophagy presents a promising strategy for cancer treatment.
  • Further research into autophagy modulators may yield new therapeutic avenues for various diseases.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K